CLINICAL TRIALS PROFILE FOR DROSPIRENONE; ETHINYL ESTRADIOL
✉ Email this page to a colleague
All Clinical Trials for drospirenone; ethinyl estradiol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00413062 ↗ | Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-06-01 | The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years. |
NCT00511199 ↗ | Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-05-01 | The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years. |
NCT00511433 ↗ | Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2006-10-01 | The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function. |
NCT00567164 ↗ | Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ | Completed | Bayer | Phase 3 | 2007-10-01 | The purpose of this study is to determine whether the study drug is safe and effective. |
NCT00633360 ↗ | The Oral Contraceptive Pill for Premenstrual Worsening of Depression | Completed | Bayer | N/A | 2008-02-01 | To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression. |
NCT00633360 ↗ | The Oral Contraceptive Pill for Premenstrual Worsening of Depression | Completed | Massachusetts General Hospital | N/A | 2008-02-01 | To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for drospirenone; ethinyl estradiol
Condition Name
Clinical Trial Locations for drospirenone; ethinyl estradiol
Trials by Country
Clinical Trial Progress for drospirenone; ethinyl estradiol
Clinical Trial Phase
Clinical Trial Sponsors for drospirenone; ethinyl estradiol
Sponsor Name